Jannie P Wijnen Selected Research

phosphorylethanolamine (phosphoethanolamine)

1/2019	Contradiction between amide-CEST signal and pH in breast cancer explained with metabolic MRI.
1/2018	Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells.
1/2014	1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models.
8/2012	Quantitative 31P magnetic resonance spectroscopy of the human breast at 7 T.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jannie P Wijnen Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 10/2019 - 08/2012
6	Neoplasms (Cancer) 10/2019 - 06/2010
2	Migraine Disorders (Migraine) 01/2021 - 07/2017
2	Epilepsy (Aura) 01/2021 - 07/2017
2	Glioma (Gliomas) 01/2021 - 06/2010
2	Schizophrenia (Dementia Praecox) 01/2017 - 01/2016
1	Premature Birth (Birth, Premature) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Brain Diseases (Brain Disorder) 01/2019
1	Cataract (Cataracts) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Autism Spectrum Disorder 01/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2016
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2016
1	Mental Disorders (Mental Disorder) 01/2016
1	Panic Disorder (Panic Attack) 01/2016
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016
1	Brain Neoplasms (Brain Tumor) 06/2010

Drug/Important Bio-Agent (IBA)

6	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
4	phosphorylethanolamine (phosphoethanolamine)IBA 01/2019 - 08/2012
3	Protons (Proton)IBA 01/2022 - 01/2017
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2016
3	Phospholipids (Phosphatides)FDA LinkGeneric 10/2019 - 01/2014
2	EnzymesIBA 10/2019 - 01/2019
2	Phosphorus (Red Phosphorus)IBA 10/2019 - 01/2019
2	Phosphates (Orthophosphate)IBA 10/2019 - 01/2019
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 01/2017
2	AmidesIBA 01/2019 - 01/2018
2	APTIBA 01/2019 - 01/2018
2	Phosphorylcholine (Phosphocholine)IBA 01/2014 - 08/2012
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021
1	alpha-hydroxyglutarateIBA 01/2021
1	A 7 (A-7)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 10/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	GlutaminaseIBA 01/2019
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2019
1	Choline (Choline Chloride)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Ethanolamine (Colamine)IBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	Inositol (Myoinositol)IBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Phosphocreatine (Neoton)IBA 01/2016
1	CreatineIBA 01/2016
1	glycerophosphoethanolamineIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 06/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2010
1	Tricarboxylic AcidsIBA 06/2010

Therapy/Procedure

2	Neoadjuvant Therapy 01/2019 - 01/2018
1	Therapeutics 10/2019
1	Drug Therapy (Chemotherapy) 01/2016
1	Intravenous Infusions 06/2010